Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association
- PMID: 33605000
- DOI: 10.1002/ejhf.2115
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association
Abstract
In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. We also propose revised stages of HF as: At risk for HF (Stage A), Pre-HF (Stage B), Symptomatic HF (Stage C) and Advanced HF (Stage D). Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF). This includes HF with reduced ejection fraction (HFrEF): symptomatic HF with LVEF ≤40%; HF with mildly reduced ejection fraction (HFmrEF): symptomatic HF with LVEF 41-49%; HF with preserved ejection fraction (HFpEF): symptomatic HF with LVEF ≥50%; and HF with improved ejection fraction (HFimpEF): symptomatic HF with a baseline LVEF ≤40%, a ≥10 point increase from baseline LVEF, and a second measurement of LVEF > 40%.
Keywords: Cardiomyopathy; Definition of heart failure; HFmrEF; HFpEF; HFrEF; Heart failure; Stages of heart failure.
© 2021 European Society of Cardiology and Elsevier, Inc.
Comment in
-
The path to universality.Eur J Heart Fail. 2021 Mar;23(3):381-383. doi: 10.1002/ejhf.2129. Epub 2021 Mar 11. Eur J Heart Fail. 2021. PMID: 33599361 No abstract available.
Similar articles
-
Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure.J Card Fail. 2021 Mar 1:S1071-9164(21)00050-6. doi: 10.1016/j.cardfail.2021.01.022. Online ahead of print. J Card Fail. 2021. PMID: 33663906
-
Universal Definition and Classification of Heart Failure.J Card Fail. 2021 Feb 7:S1071-9164(21)00050-6. doi: 10.1016/j.cardfail.2021.01.022. Online ahead of print. J Card Fail. 2021. PMID: 33662581
-
Heart Failure With Preserved Ejection Fraction (HFpEF).2024 Mar 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 38320083 Free Books & Documents.
-
Recent advances in the pharmacological therapy of chronic heart failure: Evidence and guidelines.Pharmacol Ther. 2022 Oct;238:108185. doi: 10.1016/j.pharmthera.2022.108185. Epub 2022 Apr 9. Pharmacol Ther. 2022. PMID: 35413307 Review.
-
Left ventricular ejection fraction as therapeutic target: is it the ideal marker?Heart Fail Rev. 2017 Nov;22(6):641-655. doi: 10.1007/s10741-017-9624-5. Heart Fail Rev. 2017. PMID: 28601914 Review.
Cited by
-
Cognitive Impairment and Synaptic Dysfunction in Cardiovascular Disorders: The New Frontiers of the Heart-Brain Axis.Biomedicines. 2024 Oct 18;12(10):2387. doi: 10.3390/biomedicines12102387. Biomedicines. 2024. PMID: 39457698 Free PMC article. Review.
-
Heart Failure with Preserved Ejection Fraction: The Pathophysiological Mechanisms behind the Clinical Phenotypes and the Therapeutic Approach.Int J Mol Sci. 2024 Jan 8;25(2):794. doi: 10.3390/ijms25020794. Int J Mol Sci. 2024. PMID: 38255869 Free PMC article. Review.
-
Prognostic Value of Baseline Echocardiographic Parameters in Heart Failure With Improved vs Nonrecovered Ejection Fraction.CJC Open. 2023 Aug 23;5(12):859-869. doi: 10.1016/j.cjco.2023.08.006. eCollection 2023 Dec. CJC Open. 2023. PMID: 38204844 Free PMC article.
-
Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis.Front Cardiovasc Med. 2024 Sep 11;11:1388337. doi: 10.3389/fcvm.2024.1388337. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39323760 Free PMC article.
-
Prognostic Impact of Echocardiographic Congestion Grade in HFpEF With and Without Atrial Fibrillation.JACC Asia. 2022 Jan 18;2(1):73-84. doi: 10.1016/j.jacasi.2021.10.012. eCollection 2022 Feb. JACC Asia. 2022. PMID: 36340256 Free PMC article.
References
-
- Braunwald E. Heart failure. JACC Heart Fail 2013;1:1-20.
-
- Wagner S, Cohn K. Heart failure. A proposed definition and classification. Arch Intern Med 1977;137:675-678.
-
- Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;128:e240-e327.
-
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016;18:891-975.
-
- Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, Kitakaze M, Kinugawa K, Kihara Y, Goto Y, Komuro I, Saiki Y, Saito Y, Sakata Y, Sato N, Sawa Y, Shiose A, Shimizu W, Shimokawa H, Seino Y, Node K, Higo T, Hirayama A, Makaya M, Masuyama T, Murohara T, Momomura SI, Yano M, Yamazaki K, Yamamoto K, Yoshikawa T, Yoshimura M, Akiyama M, Anzai T, Ishihara S, Inomata T, Imamura T, Iwasaki YK, Ohtani T, Onishi K, Kasai T, Kato M, Kawai M, Kinugasa Y, Kinugawa S, Kuratani T, Kobayashi S, Sakata Y, Tanaka A, Toda K, Noda T, Nochioka K, Hatano M, Hidaka T, Fujino T, Makita S, Yamaguchi O, Ikeda U, Kimura T, Kohsaka S, Kosuge M, Yamagishi M, Yamashina A; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version. Circ J 2019;83:2084-2184.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous